Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DRNA | Common Stock | Purchase | $71K | +3K | +90.01% | $23.66 | 6.33K | Aug 10, 2021 | Direct | F1 |
holding | DRNA | Common Stock | 5K | Aug 10, 2021 | By Marc D. Kozin Revocable Trust |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $23.455 to $23.840, inclusive. The Reporting Person undertakes to provide to Dicerna Pharmaceuticals, Inc., any security holder of Dicerna Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. |